Welcome to Regenerative Longevity.

We are a regenerative intelligence platform bringing discipline, clinical integrity, and uncompromising quality to biologic medicine.

Not all regenerative medicine is created equal. We prioritize product quality, procedural excellence, and structured clinical oversight.

Licensed Technology Access

PranaX has licensed exosome technology from The University of Texas MD Anderson Cancer Center to develop exosomes for commercial and clinical use.

GMP Manufacturing Standards

Production occurs in a Houston-based GMP-compliant facility designed to support consistent, documented biologic manufacturing.

Physician-Directed Oversight

All programs are structured within licensed medical frameworks, with screening and clinical evaluation guiding eligibility.

Documented Safety Evaluation

The licensed technology was part of the first FDA-approved safety trial evaluating mesenchymal stem cell derived exosomes in cancer patients.

Investigational Applications

Exosome uses in wellness and longevity remain under clinical evaluation and are not FDA-approved for most indications.

Longevity-Focused Strategy

Programs are designed to support healthy aging and cellular communication within structured, physician-guided frameworks.

We are not a trend.

We are not a medspa injection ad.

We are structured regenerative medicine.

Disciplined Exosome Wellness Strategy

Disciplined Exosome Wellness Strategy

GMP Manufacturing in Houston

Physician-Directed Protocol Design

ExoWELL™ is manufactured using technology licensed from The University of Texas MD Anderson Cancer Center. Production occurs in a Houston-based GMP-compliant facility.

This is not casual sourcing. It is structured biologic manufacturing supported by documented safety evaluation. Applications remain investigational.

Exosome Banking for the Future

ExoSTORE™ provides personalized collection and banking of exosomes derived from circulating blood and select birth tissue sources. 

Unlike traditional cell banking, exosome banking focuses on preserving cellular signaling vesicles. It is designed as a long-term biologic preservation strategy within an evolving clinical landscape.

 

Regenerative Longevity. At a Glance.

We partner with licensed physicians to deliver investigational exosome wellness strategies supported by licensed technology and GMP manufacturing standards.

The underlying technology was part of the first FDA-approved safety trial evaluating mesenchymal stem cell derived exosomes in cancer patients.

Exosome applications described here are investigational and not FDA-approved for most indications. Outcomes vary.

Pricing

Choose A Plan

Our Clients

Testimonials

See what our satisfied customers are saying about Regenerative Longevity Their experiences speak to our commitment to reliable and efficient Regenerative solutions.

"What stood out to me was the discipline. No hype, no exaggerated promises. Just a structured conversation about what’s possible and what’s still investigational. That level of transparency mattered."

— Private Client

“I’ve explored regenerative options before, but this was the first time I felt confident about the sourcing and manufacturing standards behind the product.”

— Client, Houston

“The consult felt more like a strategy session than a sales pitch. They walked through safety data, regulatory status, and realistic expectations. That built trust.”

— Wellness Client

Get Started Today

Ready to transform your payroll process? Sign up now and enjoy a free trial—experience the ease of smart payroll management first hand!